What do women think about having received their breast cancer risk as part of a risk-stratified NHS Breast Screening Programme? A qualitative study
Name:
37225893.pdf
Size:
507.6Kb
Format:
PDF
Description:
Identified with Open Access button
Affiliation
Manchester Centre for Health Psychology, Division of Psychology & Mental Health, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, MAHSC, Oxford Road, M13 9PL, Manchester, UKIssue Date
2023
Metadata
Show full item recordAbstract
Background: Risk-stratified screening is being considered for national breast screening programmes. It is unclear how women experience risk-stratified screening and receipt of breast cancer risk information in real time. This study aimed to explore the psychological impact of undergoing risk-stratified screening within England's NHS Breast Screening Programme. Methods: Individual telephone interviews were conducted with 40 women who participated in the BC-Predict study and received a letter indicating their estimated breast cancer risk as one of four risk categories: low (<2% 10-year risk), average (2-4.99%), above average (moderate; 5-7.99%) or high (≥8%). Audio-recorded interview transcriptions were analysed using reflexive thematic analysis. Results: Two themes were produced: 'From risk expectations to what's my future health story?' highlights that women overall valued the opportunity to receive risk estimates; however, when these were discordant with perceived risk, this causes temporary distress or rejection of the information. 'Being a good (woman) citizen' where women felt positive contributing to society but may feel judged if they then cannot exert agency over the management of their risk or access follow-up support CONCLUSIONS: Risk-stratified breast screening was generally accepted without causing long-lasting distress; however, issues related to risk communication and access to care pathways need to be considered for implementation.Citation
McWilliams L, Ruane H, Ulph F, Woof VG, Harrison F, Evans DG, et al. What do women think about having received their breast cancer risk as part of a risk-stratified NHS Breast Screening Programme? A qualitative study. British journal of cancer. 2023 May 24:1-10. PubMed PMID: 37225893. Pubmed Central PMCID: PMC10206350 AstraZeneca and Everything Genetic. Epub 2023/05/25. eng.Journal
British Journal of CancerDOI
10.1038/s41416-023-02268-0PubMed ID
37225893Additional Links
https://dx.doi.org/10.1038/s41416-023-02268-0Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1038/s41416-023-02268-0
Scopus Count
Collections
Related articles
- The introduction of risk stratified screening into the NHS breast screening Programme: views from British-Pakistani women.
- Authors: Woof VG, Ruane H, French DP, Ulph F, Qureshi N, Khan N, Evans DG, Donnelly LS
- Issue date: 2020 May 20
- Healthcare professionals' views following implementation of risk stratification into a national breast cancer screening programme.
- Authors: Hawkins R, McWilliams L, Ulph F, Evans DG, French DP
- Issue date: 2022 Oct 12
- Extending screening intervals for women at low risk of breast cancer: do they find it acceptable?
- Authors: McWilliams L, Woof VG, Donnelly LS, Howell A, Evans DG, French DP
- Issue date: 2021 May 29
- Introducing a low-risk breast screening pathway into the NHS Breast Screening Programme: Views from healthcare professionals who are delivering risk-stratified screening.
- Authors: Woof VG, McWilliams L, Donnelly LS, Howell A, Evans DG, Maxwell AJ, French DP
- Issue date: 2021 Jan-Dec
- Psychological impact of risk-stratified screening as part of the NHS Breast Screening Programme: multi-site non-randomised comparison of BC-Predict versus usual screening (NCT04359420).
- Authors: French DP, McWilliams L, Bowers S, Woof VG, Harrison F, Ruane H, Hendy A, Evans DG
- Issue date: 2023 Apr